{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T11:28:06Z","timestamp":1726054086442},"publisher-location":"Cham","reference-count":146,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030259044"},{"type":"electronic","value":"9783030259051"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-3-030-25905-1_11","type":"book-chapter","created":{"date-parts":[[2019,10,6]],"date-time":"2019-10-06T17:02:41Z","timestamp":1570381361000},"page":"213-243","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Timeline of Advances in Genetics of Primary Aldosteronism"],"prefix":"10.1007","author":[{"given":"Lucie S.","family":"Meyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Reincke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy Ann","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,7]]},"reference":[{"issue":"7","key":"11_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041926","volume":"7","author":"T \u00c5kerstr\u00f6m","year":"2012","unstructured":"\u00c5kerstr\u00f6m T, Crona J, Delgado Verdugo A et al (2012) Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter. PLoS One 7(7):e41926. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0041926","journal-title":"PLoS One"},{"issue":"5","key":"11_CR2","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1530\/erc-15-0321","volume":"22","author":"T \u00c5kerstr\u00f6m","year":"2015","unstructured":"\u00c5kerstr\u00f6m T, Willenberg HS, Cupisti K et al (2015) Novel somatic mutations and distinct molecular signature in aldosterone-producing adenomas. Endocr Relat Cancer 22(5):735\u2013744. \n                    https:\/\/doi.org\/10.1530\/erc-15-0321","journal-title":"Endocr Relat Cancer"},{"key":"11_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/srep19546","volume":"6","author":"T \u00c5kerstr\u00f6m","year":"2016","unstructured":"\u00c5kerstr\u00f6m T, Maharjan R, Sven Willenberg H et al (2016) Activating mutations in CTNNB1 in aldosterone producing adenomas. Sci Rep 6:19546. \n                    https:\/\/doi.org\/10.1038\/srep19546","journal-title":"Sci Rep"},{"issue":"5","key":"11_CR4","doi-asserted-by":"publisher","first-page":"E819","DOI":"10.1210\/jc.2011-2965","volume":"97","author":"EA Azizan","year":"2012","unstructured":"Azizan EA, Lam BY, Newhouse SJ et al (2012) Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors. J Clin Endocrinol Metab 97(5):E819\u2013E829. \n                    https:\/\/doi.org\/10.1210\/jc.2011-2965","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"11_CR5","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/ng.2716","volume":"45","author":"EA Azizan","year":"2013","unstructured":"Azizan EA, Poulsen H, Tuluc P et al (2013) Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension. Nat Genet 45(9):1055\u20131060. \n                    https:\/\/doi.org\/10.1038\/ng.2716","journal-title":"Nat Genet"},{"issue":"7","key":"11_CR6","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1097\/hjh.0000000000001735","volume":"36","author":"S Baron","year":"2018","unstructured":"Baron S, Amar L, Faucon AL et al (2018) Criteria for diagnosing primary aldosteronism on the basis of liquid chromatography-tandem mass spectrometry determinations of plasma aldosterone concentration. J Hypertens 36(7):1592\u20131601. \n                    https:\/\/doi.org\/10.1097\/hjh.0000000000001735","journal-title":"J Hypertens"},{"issue":"6","key":"11_CR7","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/bies.950170605","volume":"17","author":"MJ Berridge","year":"1995","unstructured":"Berridge MJ (1995) Calcium signalling and cell proliferation. BioEssays 17(6):491\u2013500. \n                    https:\/\/doi.org\/10.1002\/bies.950170605","journal-title":"BioEssays"},{"issue":"4","key":"11_CR8","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1093\/hmg\/ddt484","volume":"23","author":"A Berthon","year":"2014","unstructured":"Berthon A, Drelon C, Ragazzon B et al (2014) WNT\/beta-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production. Hum Mol Genet 23(4):889\u2013905. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddt484","journal-title":"Hum Mol Genet"},{"issue":"4","key":"11_CR9","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/ng.2550","volume":"45","author":"F Beuschlein","year":"2013","unstructured":"Beuschlein F, Boulkroun S, Osswald A et al (2013) Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. Nat Genet 45(4):440\u2013444., 444e1-2. \n                    https:\/\/doi.org\/10.1038\/ng.2550","journal-title":"Nat Genet"},{"issue":"5","key":"11_CR10","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1161\/hypertensionaha.110.158543","volume":"56","author":"S Boulkroun","year":"2010","unstructured":"Boulkroun S, Samson-Couterie B, Dzib JF et al (2010) Adrenal cortex remodeling and functional zona glomerulosa hyperplasia in primary aldosteronism. Hypertension 56(5):885\u2013892. \n                    https:\/\/doi.org\/10.1161\/hypertensionaha.110.158543","journal-title":"Hypertension"},{"issue":"3","key":"11_CR11","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1161\/hypertensionaha.111.186478","volume":"59","author":"S Boulkroun","year":"2012","unstructured":"Boulkroun S, Beuschlein F, Rossi GP et al (2012) Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism. Hypertension 59(3):592\u2013598. \n                    https:\/\/doi.org\/10.1161\/hypertensionaha.111.186478","journal-title":"Hypertension"},{"issue":"2","key":"11_CR12","doi-asserted-by":"publisher","first-page":"a004168","DOI":"10.1101\/cshperspect.a004168","volume":"3","author":"M Brini","year":"2011","unstructured":"Brini M, Carafoli E (2011) The plasma membrane Ca(2)+ ATPase and the plasma membrane sodium calcium exchanger cooperate in the regulation of cell calcium. Cold Spring Harb Perspect Biol 3(2):a004168. \n                    https:\/\/doi.org\/10.1101\/cshperspect.a004168","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"11_CR13","doi-asserted-by":"publisher","unstructured":"Burrello J, Burrello A, Stowasser M et al (2019) The primary aldosteronism surgical outcome score for the prediction of clinical outcomes after adrenalectomy for unilateral primary aldosteronism. Ann Surg. \n                    https:\/\/doi.org\/10.1097\/SLA.0000000000003200","DOI":"10.1097\/SLA.0000000000003200"},{"issue":"6","key":"11_CR14","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","volume":"40","author":"DA Calhoun","year":"2002","unstructured":"Calhoun DA, Nishizaka MK, Zaman MA, Thakkar RB, Weissmann P (2002) Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension 40(6):892\u2013896","journal-title":"Hypertension"},{"issue":"2","key":"11_CR15","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3275\/717110.1007\/bf03347044","volume":"34","author":"CA Carvajal","year":"2011","unstructured":"Carvajal CA, Stehr CB, Gonzalez PA et al (2011) A de novo unequal cross-over mutation between CYP11B1 and CYP11B2 genes causes familial hyperaldosteronism type I. J Endocrinol Investig 34(2):140\u2013144. \n                    https:\/\/doi.org\/10.3275\/717110.1007\/bf03347044","journal-title":"J Endocrinol Investig"},{"key":"11_CR16","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1136\/pgmj.36.413.198","volume":"36","author":"TM Chalmers","year":"1960","unstructured":"Chalmers TM (1960) Conn's syndrome. Postgrad Med J 36:198\u2013200","journal-title":"Postgrad Med J"},{"issue":"6018","key":"11_CR17","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1126\/science.1198785","volume":"331","author":"M Choi","year":"2011","unstructured":"Choi M, Scholl UI, Yue P et al (2011) K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science (New York, NY) 331(6018):768\u2013772. \n                    https:\/\/doi.org\/10.1126\/science.1198785","journal-title":"Science (New York, NY)"},{"issue":"4","key":"11_CR18","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1080\/07435809609043735","volume":"22","author":"CD Clyne","year":"1996","unstructured":"Clyne CD, White PC, Rainey WE (1996) Calcium regulates human CYP11B2 transcription. Endocr Res 22(4):485\u2013492","journal-title":"Endocr Res"},{"issue":"1","key":"11_CR19","first-page":"3","volume":"45","author":"JW Conn","year":"1955","unstructured":"Conn JW (1955) Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome. J Lab Clin Med 45(1):3\u201317","journal-title":"J Lab Clin Med"},{"key":"11_CR20","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ebiom.2016.10.002","volume":"13","author":"G Daniil","year":"2016","unstructured":"Daniil G, Fernandes-Rosa FL, Chemin J et al (2016) CACNA1H mutations are associated with different forms of primary aldosteronism. EBioMedicine 13:225\u2013236. \n                    https:\/\/doi.org\/10.1016\/j.ebiom.2016.10.002","journal-title":"EBioMedicine"},{"issue":"7","key":"11_CR21","doi-asserted-by":"publisher","first-page":"E1341","DOI":"10.1210\/jc.2013-4255","volume":"99","author":"T Dekkers","year":"2014","unstructured":"Dekkers T, ter Meer M, Lenders JW et al (2014) Adrenal nodularity and somatic mutations in primary aldosteronism: one node is the culprit? J Clin Endocrinol Metab 99(7):E1341\u2013E1351. \n                    https:\/\/doi.org\/10.1210\/jc.2013-4255","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"11_CR22","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1373\/clinchem.2015.251199","volume":"62","author":"G Eisenhofer","year":"2016","unstructured":"Eisenhofer G, Dekkers T, Peitzsch M et al (2016) Mass spectrometry-based adrenal and peripheral venous steroid profiling for subtyping primary aldosteronism. Clin Chem 62(3):514\u2013524. \n                    https:\/\/doi.org\/10.1373\/clinchem.2015.251199","journal-title":"Clin Chem"},{"issue":"2","key":"11_CR23","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1161\/hypertensionaha.114.03419","volume":"64","author":"FL Fernandes-Rosa","year":"2014","unstructured":"Fernandes-Rosa FL, Williams TA, Riester A et al (2014) Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma. Hypertension 64(2):354\u2013361. \n                    https:\/\/doi.org\/10.1161\/hypertensionaha.114.03419","journal-title":"Hypertension"},{"key":"11_CR24","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.mce.2015.01.020","volume":"408","author":"FL Fernandes-Rosa","year":"2015","unstructured":"Fernandes-Rosa FL, Amar L, Tissier F et al (2015a) Functional histopathological markers of aldosterone producing adenoma and somatic KCNJ5 mutations. Mol Cell Endocrinol 408:220\u2013226. \n                    https:\/\/doi.org\/10.1016\/j.mce.2015.01.020","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"11_CR25","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1161\/hypertensionaha.115.05993","volume":"66","author":"FL Fernandes-Rosa","year":"2015","unstructured":"Fernandes-Rosa FL, Giscos-Douriez I, Amar L et al (2015b) Different somatic mutations in multinodular adrenals with aldosterone-producing adenoma. Hypertension 66(5):1014\u20131022. \n                    https:\/\/doi.org\/10.1161\/hypertensionaha.115.05993","journal-title":"Hypertension"},{"issue":"1","key":"11_CR26","doi-asserted-by":"publisher","first-page":"R47","DOI":"10.1530\/jme-17-0035","volume":"59","author":"FL Fernandes-Rosa","year":"2017","unstructured":"Fernandes-Rosa FL, Boulkroun S, Zennaro MC (2017) Somatic and inherited mutations in primary aldosteronism. J Mol Endocrinol 59(1):R47\u2013r63. \n                    https:\/\/doi.org\/10.1530\/jme-17-0035","journal-title":"J Mol Endocrinol"},{"issue":"3","key":"11_CR27","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41588-018-0053-8","volume":"50","author":"FL Fernandes-Rosa","year":"2018","unstructured":"Fernandes-Rosa FL, Daniil G, Orozco IJ et al (2018) A gain-of-function mutation in the CLCN2 chloride channel gene causes primary aldosteronism. Nat Genet 50(3):355\u2013361. \n                    https:\/\/doi.org\/10.1038\/s41588-018-0053-8","journal-title":"Nat Genet"},{"issue":"5","key":"11_CR28","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F et al (2016) The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 101(5):1889\u20131916. \n                    https:\/\/doi.org\/10.1210\/jc.2015-4061","journal-title":"J Clin Endocrinol Metab"},{"issue":"14","key":"11_CR29","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1056\/nejm199210013271417","volume":"327","author":"M Gagner","year":"1992","unstructured":"Gagner M, Lacroix A, Bolte E (1992) Laparoscopic adrenalectomy in Cushing\u2019s syndrome and pheochromocytoma. New Engl J Med 327(14):1033. \n                    https:\/\/doi.org\/10.1056\/nejm199210013271417","journal-title":"New Engl J Med"},{"issue":"8","key":"11_CR30","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1210\/jc.2008-0594","volume":"93","author":"DS Geller","year":"2008","unstructured":"Geller DS, Zhang J, Wisgerhof MV, Shackleton C, Kashgarian M, Lifton RP (2008) A novel form of human Mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab 93(8):3117\u20133123. \n                    https:\/\/doi.org\/10.1210\/jc.2008-0594","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"11_CR31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1210\/en.2013-1733","volume":"155","author":"CE Gomez-Sanchez","year":"2014","unstructured":"Gomez-Sanchez CE, Oki K (2014) Minireview: Potassium channels and aldosterone dysregulation: is primary aldosteronism a potassium channelopathy? Endocrinology 155(1):47\u201355. \n                    https:\/\/doi.org\/10.1210\/en.2013-1733","journal-title":"Endocrinology"},{"issue":"6","key":"11_CR32","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1161\/hypertensionaha.118.11369","volume":"72","author":"CE Gomez-Sanchez","year":"2018","unstructured":"Gomez-Sanchez CE, Williams TA (2018) Visualizing adrenal steroids in primary aldosteronism. Hypertension 72(6):1269\u20131271. \n                    https:\/\/doi.org\/10.1161\/hypertensionaha.118.11369","journal-title":"Hypertension"},{"issue":"5","key":"11_CR33","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1210\/jcem-59-5-1022","volume":"59","author":"CE Gomez-Sanchez","year":"1984","unstructured":"Gomez-Sanchez CE, Montgomery M, Ganguly A et al (1984) Elevated urinary excretion of 18-oxocortisol in glucocorticoid-suppressible aldosteronism. J Clin Endocrinol Metab 59(5):1022\u20131024. \n                    https:\/\/doi.org\/10.1210\/jcem-59-5-1022","journal-title":"J Clin Endocrinol Metab"},{"issue":"1\u20132","key":"11_CR34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.mce.2013.11.022","volume":"383","author":"CE Gomez-Sanchez","year":"2014","unstructured":"Gomez-Sanchez CE, Qi X, Velarde-Miranda C et al (2014) Development of monoclonal antibodies against human CYP11B1 and CYP11B2. Mol Cell Endocrinol 383(1\u20132):111\u2013117. \n                    https:\/\/doi.org\/10.1016\/j.mce.2013.11.022","journal-title":"Mol Cell Endocrinol"},{"issue":"12","key":"11_CR35","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1055\/s-0043-122238","volume":"49","author":"CE Gomez-Sanchez","year":"2017","unstructured":"Gomez-Sanchez CE, Kuppusamy M, Reincke M, Williams TA (2017a) Disordered CYP11B2 expression in primary aldosteronism. Horm Metab Res 49(12):957\u2013962. \n                    https:\/\/doi.org\/10.1055\/s-0043-122238","journal-title":"Horm Metab Res"},{"key":"11_CR36","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.mce.2016.10.025","volume":"439","author":"CE Gomez-Sanchez","year":"2017","unstructured":"Gomez-Sanchez CE, Qi X, Gomez-Sanchez EP, Sasano H, Bohlen MO, Wisgerhof M (2017b) Disordered zonal and cellular CYP11B2 enzyme expression in familial hyperaldosteronism type 3. Mol Cell Endocrinol 439:74\u201380. \n                    https:\/\/doi.org\/10.1016\/j.mce.2016.10.025","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"11_CR37","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1440-1681.1991.tb01446.x","volume":"18","author":"RD Gordon","year":"1991","unstructured":"Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Finn WL, Krek AL (1991) Clinical and pathological diversity of primary aldosteronism, including a new familial variety. Clin Exp Pharm Physiol 18(5):283\u2013286","journal-title":"Clin Exp Pharm Physiol"},{"issue":"8812","key":"11_CR38","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0140-6736(92)93225-C","volume":"340","author":"RD Gordon","year":"1992","unstructured":"Gordon RD, Klemm SA, Tunny TJ, Stowasser M (1992) Primary aldosteronism: hypertension with a genetic basis. Lancet 340(8812):159\u2013161","journal-title":"Lancet"},{"issue":"5","key":"11_CR39","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1440-1681.1993.tb01687.x","volume":"20","author":"RD Gordon","year":"1993","unstructured":"Gordon RD, Ziesak MD, Tunny TJ, Stowasser M, Klemm SA (1993) Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers. Clin Exp Pharm Physiol 20(5):296\u2013298","journal-title":"Clin Exp Pharm Physiol"},{"issue":"4","key":"11_CR40","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1440-1681.1994.tb02519.x","volume":"21","author":"RD Gordon","year":"1994","unstructured":"Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC (1994) High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharm Physiol 21(4):315\u2013318","journal-title":"Clin Exp Pharm Physiol"},{"issue":"4306","key":"11_CR41","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/169795a0","volume":"169","author":"HM Grundy","year":"1952","unstructured":"Grundy HM, Simpson SA, Tait JF (1952) Isolation of a highly active mineralocorticoid from beef adrenal extract. Nature 169(4306):795\u2013796","journal-title":"Nature"},{"issue":"11","key":"11_CR42","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1210\/jc.2018-01041","volume":"103","author":"Z Guo","year":"2018","unstructured":"Guo Z, Poglitsch M, McWhinney BC et al (2018) Aldosterone LC-MS\/MS assay-specific threshold values in screening and confirmatory testing for primary aldosteronism. J Clin Endocrinol Metab 103(11):3965\u20133973. \n                    https:\/\/doi.org\/10.1210\/jc.2018-01041","journal-title":"J Clin Endocrinol Metab"},{"issue":"5085","key":"11_CR43","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1126\/science.1279807","volume":"258","author":"L Heginbotham","year":"1992","unstructured":"Heginbotham L, Abramson T, MacKinnon R (1992) A functional connection between the pores of distantly related ion channels as revealed by mutant K+ channels. Science (New York, NY) 258(5085):1152\u20131155","journal-title":"Science (New York, NY)"},{"issue":"1","key":"11_CR44","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/s2213-8587(17)30367-4","volume":"6","author":"GL Hundemer","year":"2018","unstructured":"Hundemer GL, Curhan GC, Yozamp N, Wang M, Vaidya A (2018) Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study. Lancet Diabetes Endocrinol 6(1):51\u201359. \n                    https:\/\/doi.org\/10.1016\/s2213-8587(17)30367-4","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"11_CR45","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1210\/jc.2018-00738","volume":"103","author":"K Inoue","year":"2018","unstructured":"Inoue K, Yamazaki Y, Kitamoto T et al (2018) Aldosterone suppression by dexamethasone in patients with KCNJ5-mutated aldosterone-producing adenoma. J Clin Endocrinol Metab 103(9):3477\u20133485. \n                    https:\/\/doi.org\/10.1210\/jc.2018-00738","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"11_CR46","doi-asserted-by":"publisher","first-page":"329","DOI":"10.7326\/0003-4819-151-5-200909010-00007","volume":"151","author":"MJ Kempers","year":"2009","unstructured":"Kempers MJ, Lenders JW, van Outheusden L et al (2009) Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism. Ann Intern Med 151(5):329\u2013337","journal-title":"Ann Intern Med"},{"issue":"2","key":"11_CR47","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1210\/jc.2015-3284","volume":"101","author":"T Kitamoto","year":"2016","unstructured":"Kitamoto T, Suematsu S, Yamazaki Y et al (2016) Clinical and steroidogenic characteristics of aldosterone-producing adenomas with ATPase or CACNA1D gene mutations. J Clin Endocrinol Metab 101(2):494\u2013503. \n                    https:\/\/doi.org\/10.1210\/jc.2015-3284","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"11_CR48","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1073\/pnas.68.4.820","volume":"68","author":"AG Knudson Jr","year":"1971","unstructured":"Knudson AG Jr (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 68(4):820\u2013823","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"11_CR49","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1136\/jmg.37.11.831","volume":"37","author":"AR Lafferty","year":"2000","unstructured":"Lafferty AR, Torpy DJ, Stowasser M et al (2000) A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22). J Med Genet 37(11):831\u2013835","journal-title":"J Med Genet"},{"key":"11_CR50","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ajhg.2018.01.023.","volume":"102","author":"P Lassuthova","year":"2018","unstructured":"Lassuthova P, Rebelo AP, Ravenscroft G et al (2018) Mutations in ATP1A1 cause dominant Charcot-Marie-tooth type 2. Am J Hum Genet 102:505\u2013514. \n                    https:\/\/doi.org\/10.1016\/j.ajhg.2018.01.023.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"11_CR51","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/eje-17-0563","volume":"178","author":"JWM Lenders","year":"2018","unstructured":"Lenders JWM, Williams TA, Reincke M, Gomez-Sanchez CE (2018) DIAGNOSIS OF ENDOCRINE DISEASE: 18-Oxocortisol and 18-hydroxycortisol: is there clinical utility of these steroids? Eur J Endocrinol 178(1):R1\u2013R9. \n                    https:\/\/doi.org\/10.1530\/eje-17-0563","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"11_CR52","doi-asserted-by":"publisher","first-page":"E1089","DOI":"10.1210\/jc.2015-2149","volume":"100","author":"L Lenzini","year":"2015","unstructured":"Lenzini L, Rossitto G, Maiolino G, Letizia C, Funder JW, Rossi GP (2015) A meta-analysis of somatic KCNJ5 K(+) channel mutations in 1636 patients with an aldosterone-producing adenoma. J Clin Endocrinol Metab 100(8):E1089\u2013E1095. \n                    https:\/\/doi.org\/10.1210\/jc.2015-2149","journal-title":"J Clin Endocrinol Metab"},{"issue":"6357","key":"11_CR53","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/355262a0","volume":"355","author":"RP Lifton","year":"1992","unstructured":"Lifton RP, Dluhy RG, Powers M et al (1992a) A chimaeric 11 beta-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355(6357):262\u2013265. \n                    https:\/\/doi.org\/10.1038\/355262a0","journal-title":"Nature"},{"key":"11_CR54","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/ng0992-66","volume":"2","author":"RP Lifton","year":"1992","unstructured":"Lifton RP, Dluhy RG, Powers M et al (1992b) Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase. Nat Genet 2:66\u201374. \n                    https:\/\/doi.org\/10.1038\/ng0992-66","journal-title":"Nat Genet"},{"issue":"1 Pt 2","key":"11_CR55","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1161\/01.HYP.31.1.445","volume":"31","author":"WR Litchfield","year":"1998","unstructured":"Litchfield WR, Anderson BF, Weiss RJ, Lifton RP, Dluhy RG (1998) Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism. Hypertension 31(1 Pt 2):445\u2013450","journal-title":"Hypertension"},{"issue":"12","key":"11_CR56","doi-asserted-by":"publisher","first-page":"4328","DOI":"10.1210\/jcem.83.12.5309","volume":"83","author":"AA MacConnachie","year":"1998","unstructured":"MacConnachie AA, Kelly KF, McNamara A et al (1998) Rapid diagnosis and identification of cross-over sites in patients with glucocorticoid remediable aldosteronism. J Clin Endocrinol Metab 83(12):4328\u20134331. \n                    https:\/\/doi.org\/10.1210\/jcem.83.12.5309","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"11_CR57","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","volume":"17","author":"BT MacDonald","year":"2009","unstructured":"MacDonald BT, Tamai K, He X (2009) Wnt\/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17(1):9\u201326. \n                    https:\/\/doi.org\/10.1016\/j.devcel.2009.06.016","journal-title":"Dev Cell"},{"issue":"Pt 1","key":"11_CR58","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1469-7793.2001.0027k.x","volume":"537","author":"R Marksteiner","year":"2001","unstructured":"Marksteiner R, Schurr P, Berjukow S, Margreiter E, Perez-Reyes E, Hering S (2001) Inactivation determinants in segment IIIS6 of Ca(v)3.1. J Physiol 537(Pt 1):27\u201334","journal-title":"J Physiol"},{"issue":"3","key":"11_CR59","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.jamcollsurg.2010.05.006","volume":"211","author":"A Mathur","year":"2010","unstructured":"Mathur A, Kemp CD, Dutta U et al (2010) Consequences of adrenal venous sampling in primary hyperaldosteronism and predictors of unilateral adrenal disease. J Am Coll Surg 211(3):384\u2013390. \n                    https:\/\/doi.org\/10.1016\/j.jamcollsurg.2010.05.006","journal-title":"J Am Coll Surg"},{"issue":"20","key":"11_CR60","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1056\/nejm196711162772002","volume":"277","author":"JC Melby","year":"1967","unstructured":"Melby JC, Spark RF, Dale SL, Egdahl RH, Kahn PC (1967) Diagnosis and localization of aldosterone-producing adenomas by adrenal-vein catheterization. New Engl J Med 277(20):1050\u20131056. \n                    https:\/\/doi.org\/10.1056\/nejm196711162772002","journal-title":"New Engl J Med"},{"issue":"3","key":"11_CR61","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1161\/hypertensionaha.118.11465","volume":"72","author":"LS Meyer","year":"2018","unstructured":"Meyer LS, Wang X, Susnik E et al (2018) Immunohistopathology and steroid profiles associated with biochemical outcomes after adrenalectomy for unilateral primary aldosteronism. Hypertension 72(3):650\u2013657. \n                    https:\/\/doi.org\/10.1161\/hypertensionaha.118.11465","journal-title":"Hypertension"},{"issue":"1","key":"11_CR62","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1210\/er.2010-0013","volume":"32","author":"WL Miller","year":"2011","unstructured":"Miller WL, Auchus RJ (2011) The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev 32(1):81\u2013151. \n                    https:\/\/doi.org\/10.1210\/er.2010-0013","journal-title":"Endocr Rev"},{"issue":"1","key":"11_CR63","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1507\/endocrj.EJ13-0353","volume":"61","author":"Y Miyake","year":"2014","unstructured":"Miyake Y, Tanaka K, Nishikawa T et al (2014) Prognosis of primary aldosteronism in Japan: results from a nationwide epidemiological study. Endocr J 61(1):35\u201340","journal-title":"Endocr J"},{"key":"11_CR64","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.mce.2015.04.022","volume":"411","author":"S Monticone","year":"2015","unstructured":"Monticone S, Castellano I, Versace K et al (2015) Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas. Mol Cell Endocrinol 411:146\u2013154. \n                    https:\/\/doi.org\/10.1016\/j.mce.2015.04.022","journal-title":"Mol Cell Endocrinol"},{"issue":"14","key":"11_CR65","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","volume":"69","author":"S Monticone","year":"2017","unstructured":"Monticone S, Burrello J, Tizzani D et al (2017a) Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J Am Coll Cardiol 69(14):1811\u20131820. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2017.01.052","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"11_CR66","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/jhh.2017.34","volume":"31","author":"S Monticone","year":"2017","unstructured":"Monticone S, Tetti M, Burrello J et al (2017b) Familial hyperaldosteronism type III. J Hum Hypertens 31(12):776\u2013781. \n                    https:\/\/doi.org\/10.1038\/jhh.2017.34","journal-title":"J Hum Hypertens"},{"issue":"3","key":"11_CR67","doi-asserted-by":"publisher","first-page":"R101","DOI":"10.1530\/eje-17-0946","volume":"178","author":"S Monticone","year":"2018","unstructured":"Monticone S, Buffolo F, Tetti M, Veglio F, Pasini B, Mulatero P (2018a) GENETICS IN ENDOCRINOLOGY: the expanding genetic horizon of primary aldosteronism. Eur J Endocrinol 178(3):R101\u2013r111. \n                    https:\/\/doi.org\/10.1530\/eje-17-0946","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"11_CR68","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/s2213-8587(17)30319-4","volume":"6","author":"S Monticone","year":"2018","unstructured":"Monticone S, D'Ascenzo F, Moretti C et al (2018b) Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol 6(1):41\u201350. \n                    https:\/\/doi.org\/10.1016\/s2213-8587(17)30319-4","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3 Pt 2","key":"11_CR69","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1161\/01.HYP.38.3.688","volume":"38","author":"L Mosso","year":"2001","unstructured":"Mosso L, Gomez-Sanchez CE, Foecking MF, Fardella C (2001) Serum 18-hydroxycortisol in primary aldosteronism, hypertension, and normotensives. Hypertension 38(3 Pt 2):688\u2013691","journal-title":"Hypertension"},{"issue":"2","key":"11_CR70","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1161\/01.Hyp.0000079505.25750.11","volume":"42","author":"L Mosso","year":"2003","unstructured":"Mosso L, Carvajal C, Gonzalez A et al (2003) Primary aldosteronism and hypertensive disease. Hypertension 42(2):161\u2013165. \n                    https:\/\/doi.org\/10.1161\/01.Hyp.0000079505.25750.11","journal-title":"Hypertension"},{"issue":"8","key":"11_CR71","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.1210\/jc.2008-1241","volume":"93","author":"P Mulatero","year":"2008","unstructured":"Mulatero P (2008) A new form of hereditary primary aldosteronism: familial hyperaldosteronism type III. J Clin Endocrinol Metab 93(8):2972\u20132974. \n                    https:\/\/doi.org\/10.1210\/jc.2008-1241","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"11_CR72","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1210\/jcem.87.7.8647","volume":"87","author":"P Mulatero","year":"2002","unstructured":"Mulatero P, di Cella SM, Williams TA et al (2002) Glucocorticoid remediable aldosteronism: low morbidity and mortality in a four-generation Italian pedigree. J Clin Endocrinol Metab 87(7):3187\u20133191. \n                    https:\/\/doi.org\/10.1210\/jcem.87.7.8647","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"11_CR73","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1210\/jc.2003-031337","volume":"89","author":"P Mulatero","year":"2004","unstructured":"Mulatero P, Stowasser M, Loh KC et al (2004) Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 89(3):1045\u20131050. \n                    https:\/\/doi.org\/10.1210\/jc.2003-031337","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"11_CR74","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1210\/jc.2011-2384","volume":"97","author":"P Mulatero","year":"2012","unstructured":"Mulatero P, di Cella SM, Monticone S et al (2012a) 18-hydroxycorticosterone, 18-hydroxycortisol, and 18-oxocortisol in the diagnosis of primary aldosteronism and its subtypes. J Clin Endocrinol Metab 97(3):881\u2013889. \n                    https:\/\/doi.org\/10.1210\/jc.2011-2384","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"11_CR75","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1161\/hypertensionaha.111.183996","volume":"59","author":"P Mulatero","year":"2012","unstructured":"Mulatero P, Tauber P, Zennaro MC et al (2012b) KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism. Hypertension 59(2):235\u2013240. \n                    https:\/\/doi.org\/10.1161\/hypertensionaha.111.183996","journal-title":"Hypertension"},{"issue":"12","key":"11_CR76","doi-asserted-by":"publisher","first-page":"4826","DOI":"10.1210\/jc.2013-2805","volume":"98","author":"P Mulatero","year":"2013","unstructured":"Mulatero P, Monticone S, Bertello C, Viola A et al (2013) Long-term cardio- and cerebrovascular events in patients with primary aldosteronism. J Clin Endocrinol Metab 98(12):4826\u20134833. \n                    https:\/\/doi.org\/10.1210\/jc.2013-2805","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"11_CR77","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1097\/hjh.0000000000001088","volume":"34","author":"P Mulatero","year":"2016","unstructured":"Mulatero P, Monticone S, Burrello J, Veglio F, Williams TA, Funder J (2016) Guidelines for primary aldosteronism: uptake by primary care physicians in Europe. J Hypertens 34(11):2253\u20132257. \n                    https:\/\/doi.org\/10.1097\/hjh.0000000000001088","journal-title":"J Hypertens"},{"issue":"1\u20132","key":"11_CR78","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.mce.2014.05.002","volume":"392","author":"Y Nakamura","year":"2014","unstructured":"Nakamura Y, Maekawa T, Felizola SJ et al (2014) Adrenal CYP11B1\/2 expression in primary aldosteronism: immunohistochemical analysis using novel monoclonal antibodies. Mol Cell Endocrinol 392(1\u20132):73\u201379. \n                    https:\/\/doi.org\/10.1016\/j.mce.2014.05.002","journal-title":"Mol Cell Endocrinol"},{"key":"11_CR79","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.mce.2015.11.014","volume":"422","author":"Y Nakamura","year":"2016","unstructured":"Nakamura Y, Kitada M, Satoh F et al (2016) Intratumoral heterogeneity of steroidogenesis in aldosterone-producing adenoma revealed by intensive double- and triple-immunostaining for CYP11B2\/B1 and CYP17. Mol Cell Endocrinol 422:57\u201363. \n                    https:\/\/doi.org\/10.1016\/j.mce.2015.11.014","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"11_CR80","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1210\/jc.2012-3726","volume":"98","author":"K Nanba","year":"2013","unstructured":"Nanba K, Tsuiki M, Sawai K et al (2013) Histopathological diagnosis of primary aldosteronism using CYP11B2 immunohistochemistry. J Clin Endocrinol Metab 98(4):1567\u20131574. \n                    https:\/\/doi.org\/10.1210\/jc.2012-3726","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"11_CR81","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1161\/circulationaha.117.028201","volume":"136","author":"K Nanba","year":"2017","unstructured":"Nanba K, Vaidya A, Williams GH, Zheng I, Else T, Rainey WE (2017) Age-related autonomous aldosteronism. Circulation 136(4):347\u2013355. \n                    https:\/\/doi.org\/10.1161\/circulationaha.117.028201","journal-title":"Circulation"},{"issue":"10","key":"11_CR82","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1210\/jc.2018-01004","volume":"103","author":"K Nanba","year":"2018","unstructured":"Nanba K, Omata K, Else T et al (2018) Targeted molecular characterization of aldosterone-producing adenomas in white Americans. J Clin Endocrinol Metab 103(10):3869\u20133876. \n                    https:\/\/doi.org\/10.1210\/jc.2018-01004","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"11_CR83","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1210\/jc.2009-2010","volume":"95","author":"K Nishimoto","year":"2010","unstructured":"Nishimoto K, Nakagawa K, Li D et al (2010) Adrenocortical zonation in humans under normal and pathological conditions. J Clin Endocrinol Metab 95(5):2296\u20132305. \n                    https:\/\/doi.org\/10.1210\/jc.2009-2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"33","key":"11_CR84","doi-asserted-by":"publisher","first-page":"E4591","DOI":"10.1073\/pnas.1505529112","volume":"112","author":"K Nishimoto","year":"2015","unstructured":"Nishimoto K, Tomlins SA, Kuick R et al (2015) Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands. Proc Natl Acad Sci U S A 112(33):E4591\u2013E4599. \n                    https:\/\/doi.org\/10.1073\/pnas.1505529112","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11_CR85","doi-asserted-by":"publisher","first-page":"7834356","DOI":"10.1155\/2016\/7834356","volume":"2016","author":"K Nishimoto","year":"2016","unstructured":"Nishimoto K, Seki T, Hayashi Y et al (2016a) Human adrenocortical remodeling leading to aldosterone-producing cell cluster generation. Int J Endocrinol 2016:7834356. \n                    https:\/\/doi.org\/10.1155\/2016\/7834356","journal-title":"Int J Endocrinol"},{"issue":"1","key":"11_CR86","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1210\/jc.2015-3285","volume":"101","author":"K Nishimoto","year":"2016","unstructured":"Nishimoto K, Seki T, Kurihara I et al (2016b) Case report: nodule development from subcapsular aldosterone-producing cell clusters causes hyperaldosteronism. J Clin Endocrinol Metab 101(1):6\u20139. \n                    https:\/\/doi.org\/10.1210\/jc.2015-3285","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"11_CR87","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1365-2265.2009.03738.x","volume":"73","author":"EF Nogueira","year":"2010","unstructured":"Nogueira EF, Gerry D, Mantero F, Mariniello B, Rainey WE (2010) The role of TASK1 in aldosterone production and its expression in normal adrenal and aldosterone-producing adenomas. Clin Endocrinol 73(1):22\u201329. \n                    https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03738.x","journal-title":"Clin Endocrinol"},{"issue":"4","key":"11_CR88","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1210\/en.2011-1733","volume":"153","author":"K Oki","year":"2012","unstructured":"Oki K, Plonczynski MW, Luis Lam M, Gomez-Sanchez EP, Gomez-Sanchez CE (2012) Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis. Endocrinology 153(4):1774\u20131782. \n                    https:\/\/doi.org\/10.1210\/en.2011-1733","journal-title":"Endocrinology"},{"issue":"12","key":"11_CR89","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1055\/s-0043-122394","volume":"49","author":"K Omata","year":"2017","unstructured":"Omata K, Tomlins SA, Rainey WE (2017a) Aldosterone-producing cell clusters in normal and pathological states. Horm Metab Res 49(12):951\u2013956. \n                    https:\/\/doi.org\/10.1055\/s-0043-122394","journal-title":"Horm Metab Res"},{"issue":"6","key":"11_CR90","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1210\/jc.2016-4007","volume":"102","author":"K Omata","year":"2017","unstructured":"Omata K, Yamazaki Y, Nakamura Y et al (2017b) Genetic and histopathologic intertumor heterogeneity in primary aldosteronism. J Clin Endocrinol Metab 102(6):1792\u20131796. \n                    https:\/\/doi.org\/10.1210\/jc.2016-4007","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"11_CR91","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1161\/hypertensionaha.118.11086","volume":"72","author":"K Omata","year":"2018","unstructured":"Omata K, Satoh F, Morimoto R et al (2018) Cellular and genetic causes of idiopathic hyperaldosteronism. Hypertension 72(4):874\u2013880. \n                    https:\/\/doi.org\/10.1161\/hypertensionaha.118.11086","journal-title":"Hypertension"},{"issue":"8","key":"11_CR92","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1073\/pnas.86.8.2766","volume":"86","author":"M Orita","year":"1989","unstructured":"Orita M, Iwahana H, Kanazawa H et al (1989) Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci U S A 86(8):2766\u20132770","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11_CR93","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1146\/annurev.biophys.093008.131331","volume":"40","author":"MG Palmgren","year":"2011","unstructured":"Palmgren MG, Nissen P (2011) P-type ATPases. Annu Rev Biophys 40:243\u2013266. \n                    https:\/\/doi.org\/10.1146\/annurev.biophys.093008.131331","journal-title":"Annu Rev Biophys"},{"issue":"2\u201303","key":"11_CR94","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1055\/a-0713-0629","volume":"127","author":"LG Perez-Rivas","year":"2018","unstructured":"Perez-Rivas LG, Williams TA, Reincke M (2018) Inherited forms of primary hyperaldosteronism: new genes, new phenotypes and proposition of a new classification. Exp Clin Endocrinol 127(2\u201303):93\u201399. \n                    https:\/\/doi.org\/10.1055\/a-0713-0629","journal-title":"Exp Clin Endocrinol"},{"issue":"20","key":"11_CR95","doi-asserted-by":"publisher","first-page":"5839","DOI":"10.1113\/jp270672","volume":"594","author":"A Pinggera","year":"2016","unstructured":"Pinggera A, Striessnig J (2016) Cav 1.3 (CACNA1D) L-type Ca(2+) channel dysfunction in CNS disorders. J Physiol 594(20):5839\u20135849. \n                    https:\/\/doi.org\/10.1113\/jp270672","journal-title":"J Physiol"},{"issue":"15","key":"11_CR96","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1093\/hmg\/ddx175","volume":"26","author":"A Pinggera","year":"2017","unstructured":"Pinggera A, Mackenroth L, Rump A et al (2017) New gain-of-function mutation shows CACNA1D as recurrently mutated gene in autism spectrum disorders and epilepsy. Hum Mol Genet 26(15):2923\u20132932. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddx175","journal-title":"Hum Mol Genet"},{"issue":"5","key":"11_CR97","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1161\/hypertensionaha.117.10111","volume":"70","author":"ETA Prada","year":"2017","unstructured":"Prada ETA, Burrello J, Reincke M, Williams TA (2017) Old and new concepts in the molecular pathogenesis of primary aldosteronism. Hypertension 70(5):875\u2013881. \n                    https:\/\/doi.org\/10.1161\/hypertensionaha.117.10111","journal-title":"Hypertension"},{"issue":"8","key":"11_CR98","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1210\/en.2016-1170","volume":"157","author":"EN Reimer","year":"2016","unstructured":"Reimer EN, Walenda G, Seidel E, Scholl UI (2016) CACNA1H(M1549V) mutant calcium channel causes autonomous aldosterone production in HAC15 cells and is inhibited by mibefradil. Endocrinology 157(8):3016\u20133022. \n                    https:\/\/doi.org\/10.1210\/en.2016-1170","journal-title":"Endocrinology"},{"issue":"11","key":"11_CR99","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","volume":"48","author":"GP Rossi","year":"2006","unstructured":"Rossi GP, Bernini G, Caliumi C et al (2006) A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 48(11):2293\u20132300. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2006.07.059","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"11_CR100","doi-asserted-by":"publisher","first-page":"5463","DOI":"10.1073\/pnas.74.12.5463","volume":"74","author":"F Sanger","year":"1977","unstructured":"Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 74(12):5463\u20135467","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"11_CR101","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1161\/hypertensionaha.114.04453","volume":"65","author":"F Satoh","year":"2015","unstructured":"Satoh F, Morimoto R, Ono Y et al (2015) Measurement of peripheral plasma 18-oxocortisol can discriminate unilateral adenoma from bilateral diseases in patients with primary aldosteronism. Hypertension 65(5):1096\u20131102. \n                    https:\/\/doi.org\/10.1161\/hypertensionaha.114.04453","journal-title":"Hypertension"},{"issue":"2","key":"11_CR102","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1161\/hypertensionaha.113.01060","volume":"62","author":"S Savard","year":"2013","unstructured":"Savard S, Amar L, Plouin PF, Steichen O (2013) Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study. Hypertension 62(2):331\u2013336. \n                    https:\/\/doi.org\/10.1161\/hypertensionaha.113.01060","journal-title":"Hypertension"},{"issue":"3","key":"11_CR103","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/ncpendmet0430","volume":"3","author":"C Schirpenbach","year":"2007","unstructured":"Schirpenbach C, Reincke M (2007) Primary aldosteronism: current knowledge and controversies in Conn's syndrome. Nat Clin Pract Endocrinol Metab 3(3):220\u2013227. \n                    https:\/\/doi.org\/10.1038\/ncpendmet0430","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"5","key":"11_CR104","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.ajhg.2018.10.004","volume":"103","author":"KP Schlingmann","year":"2018","unstructured":"Schlingmann KP, Bandulik S, Mammen C et al (2018) Germline de novo mutations in atp1a1 cause renal hypomagnesemia, refractory seizures, and intellectual disability. Am J Hum Genet 103(5):808\u2013816. \n                    https:\/\/doi.org\/10.1016\/j.ajhg.2018.10.004","journal-title":"Am J Hum Genet"},{"issue":"7","key":"11_CR105","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1073\/pnas.1121407109","volume":"109","author":"UI Scholl","year":"2012","unstructured":"Scholl UI, Nelson-Williams C, Yue P et al (2012) Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5. Proc Natl Acad Sci U S A 109(7):2533\u20132538. \n                    https:\/\/doi.org\/10.1073\/pnas.1121407109","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"11_CR106","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/ng.2695","volume":"45","author":"UI Scholl","year":"2013","unstructured":"Scholl UI, Goh G, Stolting G et al (2013) Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism. Nat Genet 45(9):1050\u20131054. \n                    https:\/\/doi.org\/10.1038\/ng.2695","journal-title":"Nat Genet"},{"issue":"6","key":"11_CR107","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/cen.12873","volume":"83","author":"UI Scholl","year":"2015","unstructured":"Scholl UI, Healy JM, Thiel A et al (2015a) Novel somatic mutations in primary hyperaldosteronism are related to the clinical, radiological and pathological phenotype. Clin Endocrinol 83(6):779\u2013789. \n                    https:\/\/doi.org\/10.1111\/cen.12873","journal-title":"Clin Endocrinol"},{"key":"11_CR108","doi-asserted-by":"publisher","unstructured":"Scholl UI, Stolting G, Nelson-Williams C, et al. (2015b) Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism. eLife 4:e06315. doi:\n                    https:\/\/doi.org\/10.7554\/eLife.06315","DOI":"10.7554\/eLife.06315"},{"issue":"7","key":"11_CR109","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1172\/jci91733","volume":"12","author":"UI Scholl","year":"2017","unstructured":"Scholl UI, Abriola L, Zhang C et al (2017) Macrolides selectively inhibit mutant KCNJ5 potassium channels that cause aldosterone-producing adenoma. J Clin Invest 12(7):2739\u20132750. \n                    https:\/\/doi.org\/10.1172\/jci91733","journal-title":"J Clin Invest"},{"issue":"3","key":"11_CR110","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41588-018-0048-5","volume":"50","author":"UI Scholl","year":"2018","unstructured":"Scholl UI, Stolting G, Schewe J et al (2018) CLCN2 chloride channel mutations in familial hyperaldosteronism type II. Nat Genet 50(3):349\u2013354. \n                    https:\/\/doi.org\/10.1038\/s41588-018-0048-5","journal-title":"Nat Genet"},{"issue":"6","key":"11_CR111","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1210\/er.2018-00060","volume":"39","author":"TM Seccia","year":"2018","unstructured":"Seccia TM, Caroccia B, Gomez-Sanchez EP, Gomez-Sanchez CE, Rossi GP (2018) The biology of normal zona glomerulosa and aldosterone-producing adenoma: pathological implications. Endocr Rev 39(6):1029\u20131056. \n                    https:\/\/doi.org\/10.1210\/er.2018-00060","journal-title":"Endocr Rev"},{"issue":"22","key":"11_CR112","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1001\/jama.295.22.2638","volume":"295","author":"LA Sechi","year":"2006","unstructured":"Sechi LA, Novello M, Lapenna R et al (2006) Long-term renal outcomes in patients with primary aldosteronism. JAMA 295(22):2638\u20132645. \n                    https:\/\/doi.org\/10.1001\/jama.295.22.2638","journal-title":"JAMA"},{"issue":"2","key":"11_CR113","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1210\/endo-50-2-150","volume":"50","author":"SA Simpson","year":"1952","unstructured":"Simpson SA, Tait JF (1952) A quantitative method for the bioassay of the effect of adrenal cortical steroids on mineral metabolism. Endocrinology 50(2):150\u2013161. \n                    https:\/\/doi.org\/10.1210\/endo-50-2-150","journal-title":"Endocrinology"},{"issue":"9","key":"11_CR114","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/BF02155834","volume":"9","author":"SA Simpson","year":"1953","unstructured":"Simpson SA, Tait JF, Wettstein A, Neher R, Von Euw J, Reichstein T (1953) Isolierung eines neuen kristallisierten Hormons aus Nebennieren mit besonders hoher Wirksamkeit auf den Mineralstoffwechsel. Experientia 9(9):333\u2013335","journal-title":"Experientia"},{"issue":"4","key":"11_CR115","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1002\/hlca.19540370423","volume":"37","author":"SA Simpson","year":"1954","unstructured":"Simpson SA, Tait JF, Wettstein A et al (1954) Aldosteron. Isolierung und Eigenschaften. \u00dcber Bestandteile der Nebennierenrinde und verwandte Stoffe. 91. Mitteilung. Helv Chim Acta 37(4):1163\u20131200. \n                    https:\/\/doi.org\/10.1002\/hlca.19540370423","journal-title":"Helv Chim Acta"},{"issue":"2","key":"11_CR117","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1152\/physrev.00030.2003","volume":"84","author":"A Spat","year":"2004","unstructured":"Spat A, Hunyady L (2004) Control of aldosterone secretion: a model for convergence in cellular signaling pathways. Phys Rev 84(2):489\u2013539. \n                    https:\/\/doi.org\/10.1152\/physrev.00030.2003","journal-title":"Phys Rev"},{"issue":"3","key":"11_CR118","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s11906-001-0045-3","volume":"3","author":"M Stowasser","year":"2001","unstructured":"Stowasser M (2001) Primary aldosteronism: rare bird or common cause of secondary hypertension? Curr Hypertens Rep 3(3):230\u2013239","journal-title":"Curr Hypertens Rep"},{"issue":"4","key":"11_CR119","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1152\/physrev.00026.2015","volume":"96","author":"M Stowasser","year":"2016","unstructured":"Stowasser M, Gordon RD (2016) Primary aldosteronism: changing definitions and new concepts of physiology and pathophysiology both inside and outside the kidney. Phys Rev 96(4):1327\u20131384. \n                    https:\/\/doi.org\/10.1152\/physrev.00026.2015","journal-title":"Phys Rev"},{"issue":"5","key":"11_CR120","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1440-1681.1992.tb00462.x","volume":"19","author":"M Stowasser","year":"1992","unstructured":"Stowasser M, Gordon RD, Tunny TJ, Klemm SA, Finn WL, Krek AL (1992) Familial hyperaldosteronism type II: five families with a new variety of primary aldosteronism. Clin Exp Pharm Physiol 19(5):319\u2013322","journal-title":"Clin Exp Pharm Physiol"},{"issue":"6\u20137","key":"11_CR121","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/j.1440-1681.1996.tb02789.x","volume":"23","author":"M Stowasser","year":"1996","unstructured":"Stowasser M, Bachmann AW, Tunny TJ, Gordon RD (1996) Production of 18-oxo-cortisol in subtypes of primary aldosteronism. Clin Exp Pharm Physiol 23(6\u20137):591\u2013593","journal-title":"Clin Exp Pharm Physiol"},{"issue":"6","key":"11_CR122","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/j.1445-5994.1997.tb00999.x","volume":"27","author":"M Stowasser","year":"1997","unstructured":"Stowasser M, Gartside MG, Gordon RD (1997) A PCR-based method of screening individuals of all ages, from neonates to the elderly, for familial hyperaldosteronism type I. Aust NZ J Med 27(6):685\u2013690","journal-title":"Aust NZ J Med"},{"issue":"22","key":"11_CR123","first-page":"1109","volume":"95","author":"DJ Sutherland","year":"1966","unstructured":"Sutherland DJ, Ruse JL, Laidlaw JC (1966) Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. Can Med Assoc J 95(22):1109\u20131119","journal-title":"Can Med Assoc J"},{"issue":"6","key":"11_CR124","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1210\/en.2015-2029","volume":"157","author":"P Tauber","year":"2016","unstructured":"Tauber P, Aichinger B, Christ C et al (2016) Cellular pathophysiology of an adrenal adenoma-associated mutant of the plasma membrane Ca(2+)-ATPase ATP2B3. Endocrinology 157(6):2489\u20132499. \n                    https:\/\/doi.org\/10.1210\/en.2015-2029","journal-title":"Endocrinology"},{"issue":"1","key":"11_CR125","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1001\/archpedi.1959.02070020092012","volume":"98","author":"B Therien","year":"1959","unstructured":"Therien B, Mellinger RC, Caldwell JR, Howard PJ (1959) Primary aldosteronism due to adrenal hyperplasia; occurrence in a boy aged 10 years. AMA J Dis Child 98(1):90\u201399","journal-title":"AMA J Dis Child"},{"issue":"17","key":"11_CR126","doi-asserted-by":"publisher","first-page":"7622","DOI":"10.1158\/0008-5472.Can-05-0593","volume":"65","author":"F Tissier","year":"2005","unstructured":"Tissier F, Cavard C, Groussin L et al (2005) Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. Cancer Res 65(17):7622\u20137627. \n                    https:\/\/doi.org\/10.1158\/0008-5472.Can-05-0593","journal-title":"Cancer Res"},{"issue":"9\u201310","key":"11_CR127","first-page":"1771","volume":"4","author":"S Ulick","year":"1982","unstructured":"Ulick S, Chu MD (1982) Hypersecretion of a new corticosteroid, 18-hydroxycortisol in two types of adrenocortical hypertension. Clin Exp Hypertens Part A 4(9\u201310):1771\u20131777","journal-title":"Clin Exp Hypertens Part A"},{"issue":"4","key":"11_CR128","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1210\/jcem.76.4.8473399","volume":"76","author":"S Ulick","year":"1993","unstructured":"Ulick S, Blumenfeld JD, Atlas SA, Wang JZ, Vaughan ED Jr (1993) The unique steroidogenesis of the aldosteronoma in the differential diagnosis of primary aldosteronism. J Clin Endocrinol Metab 76(4):873\u2013878. \n                    https:\/\/doi.org\/10.1210\/jcem.76.4.8473399","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"11_CR129","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/cen.13582","volume":"88","author":"H Umakoshi","year":"2018","unstructured":"Umakoshi H, Ogasawara T, Takeda Y et al (2018) Accuracy of adrenal computed tomography in predicting the unilateral subtype in young patients with hypokalaemia and elevation of aldosterone in primary aldosteronism. Clin Endocrinol 88(5):645\u2013651. \n                    https:\/\/doi.org\/10.1111\/cen.13582","journal-title":"Clin Endocrinol"},{"key":"11_CR130","doi-asserted-by":"publisher","unstructured":"Volpe C, Hamberger B, Zedenius J, Juhlin CC (2019) Impact of immunohistochemistry on the diagnosis and management of primary aldosteronism: an important tool for improved patient follow-up. Scand J Surg. \n                    https:\/\/doi.org\/10.1177\/1457496918822622","DOI":"10.1177\/1457496918822622"},{"issue":"16","key":"11_CR131","doi-asserted-by":"publisher","first-page":"e708","DOI":"10.1097\/MD.0000000000000708","volume":"94","author":"B Wang","year":"2015","unstructured":"Wang B, Li X, Zhang X et al (2015) Prevalence and characterization of somatic mutations in Chinese aldosterone- aldosterone-producing adenoma patients. Medicine (Baltimore) 94(16):e708. \n                    https:\/\/doi.org\/10.1097\/MD.0000000000000708","journal-title":"Medicine (Baltimore)"},{"issue":"7189","key":"11_CR132","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/nature06884","volume":"452","author":"DA Wheeler","year":"2008","unstructured":"Wheeler DA, Srinivasan M, Egholm M et al (2008) The complete genome of an individual by massively parallel DNA sequencing. Nature 452(7189):872\u2013876. \n                    https:\/\/doi.org\/10.1038\/nature06884","journal-title":"Nature"},{"issue":"1","key":"11_CR133","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1161\/hypertensionaha.113.01733","volume":"63","author":"TA Williams","year":"2014","unstructured":"Williams TA, Monticone S, Schack VR et al (2014) Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas. Hypertension 63(1):188\u2013195. \n                    https:\/\/doi.org\/10.1161\/hypertensionaha.113.01733","journal-title":"Hypertension"},{"issue":"1","key":"11_CR134","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1161\/hypertensionaha.115.06186","volume":"67","author":"TA Williams","year":"2016","unstructured":"Williams TA, Peitzsch M, Dietz AS et al (2016) Genotype-specific steroid profiles associated with aldosterone-producing adenomas. Hypertension 67(1):139\u2013145. \n                    https:\/\/doi.org\/10.1161\/hypertensionaha.115.06186","journal-title":"Hypertension"},{"issue":"9","key":"11_CR135","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/s2213-8587(17)30135-3","volume":"5","author":"TA Williams","year":"2017","unstructured":"Williams TA, Lenders JWM, Mulatero P et al (2017) Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol 5(9):689\u2013699. \n                    https:\/\/doi.org\/10.1016\/s2213-8587(17)30135-3","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"11_CR136","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1161\/hypertensionaha.118.11382","volume":"72","author":"TA Williams","year":"2018","unstructured":"Williams TA, Burrello J, Sechi LA et al (2018) Computed tomography and adrenal venous sampling in the diagnosis of unilateral primary aldosteronism. Hypertension 72(3):641\u2013649. \n                    https:\/\/doi.org\/10.1161\/hypertensionaha.118.11382","journal-title":"Hypertension"},{"key":"11_CR137","doi-asserted-by":"publisher","DOI":"10.1038\/srep11396","volume":"5","author":"VC Wu","year":"2015","unstructured":"Wu VC, Huang KH, Peng KY et al (2015) Prevalence and clinical correlates of somatic mutation in aldosterone producing adenoma-Taiwanese population. Sci Rep 5:11396. \n                    https:\/\/doi.org\/10.1038\/srep11396","journal-title":"Sci Rep"},{"issue":"5","key":"11_CR138","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/j.1365-2265.1994.tb03008.x","volume":"40","author":"N Yamakita","year":"1994","unstructured":"Yamakita N, Mune T, Morita H, Yasuda K, Miura K, Gomez-Sanchez CE (1994) Plasma 18-oxocortisol levels in the patients with adrenocortical disorders. Clin Endocrinol 40(5):583\u2013587","journal-title":"Clin Endocrinol"},{"issue":"4","key":"11_CR139","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1210\/jc.2016-2986","volume":"102","author":"Y Yamazaki","year":"2017","unstructured":"Yamazaki Y, Nakamura Y, Omata K et al (2017) Histopathological classification of cross-sectional image-negative hyperaldosteronism. J Clin Endocrinol Metab 102(4):1182\u20131192. \n                    https:\/\/doi.org\/10.1210\/jc.2016-2986","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"11_CR140","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1161\/hypertensionaha.118.10907","volume":"72","author":"Y Yamazaki","year":"2018","unstructured":"Yamazaki Y, Omata K, Tezuka Y et al (2018) Tumor cell subtypes based on the intracellular hormonal activity in KCNJ5-mutated aldosterone-producing adenoma. Hypertension 72(3):632\u2013640. \n                    https:\/\/doi.org\/10.1161\/hypertensionaha.118.10907","journal-title":"Hypertension"},{"issue":"2\u201303","key":"11_CR141","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1055\/a-0662-6081","volume":"127","author":"Y Yang","year":"2018","unstructured":"Yang Y, Reincke M, Williams TA (2018) Treatment of unilateral pa by adrenalectomy: potential reasons for incomplete biochemical cure. Exp Clin Endocrinol 127(2\u201303):100\u2013108. \n                    https:\/\/doi.org\/10.1055\/a-0662-6081","journal-title":"Exp Clin Endocrinol"},{"key":"11_CR142","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jsbmb.2019.01.008","volume":"189","author":"Y Yang","year":"2019","unstructured":"Yang Y, Burrello J, Burrello A et al (2019) Classification of microadenomas in patients with primary aldosteronism by steroid profiling. J Steroid Biochem Mol Biol 189:274\u2013282. pii: S0960-0760(18)30479-5. \n                    https:\/\/doi.org\/10.1016\/j.jsbmb.2019.01.008","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"2","key":"11_CR143","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/joim.12831","volume":"285","author":"WF Young Jr","year":"2019","unstructured":"Young WF Jr (2019) Diagnosis and treatment of primary aldosteronism: practical clinical perspectives. J Intern Med 285(2):126\u2013148. \n                    https:\/\/doi.org\/10.1111\/joim.12831","journal-title":"J Intern Med"},{"key":"11_CR144","doi-asserted-by":"publisher","first-page":"14514","DOI":"10.1073\/pnas.1207488109","volume":"109","author":"G Zanni","year":"2012","unstructured":"Zanni G, Cali T, Kalscheuer VM et al (2012) Mutation of plasma membrane Ca(2+) ATPase isoform 3 in a family with X-linked congenital cerebellar ataxia impairs Ca(2+) homeostasis. Proc Natl Acad Sci U S A 109:14514\u201314519. \n                    https:\/\/doi.org\/10.1073\/pnas.1207488109","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"11_CR145","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1210\/er.2017-00189","volume":"38","author":"MC Zennaro","year":"2017","unstructured":"Zennaro MC, Boulkroun S, Fernandes-Rosa F (2017) Genetic causes of functional adrenocortical adenomas. Endocr Rev 38(6):516\u2013537. \n                    https:\/\/doi.org\/10.1210\/er.2017-00189","journal-title":"Endocr Rev"},{"issue":"3","key":"11_CR146","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/med.0000000000000409","volume":"25","author":"MC Zennaro","year":"2018","unstructured":"Zennaro MC, Fernandes-Rosa FL, Boulkroun S (2018) Overview of aldosterone-related genetic syndromes and recent advances. Curr Opin Endocrinol Diab Obes 25(3):147\u2013154. \n                    https:\/\/doi.org\/10.1097\/med.0000000000000409","journal-title":"Curr Opin Endocrinol Diab Obes"},{"issue":"3","key":"11_CR147","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1161\/hypertensionaha.114.03346","volume":"65","author":"FF Zheng","year":"2015","unstructured":"Zheng FF, Zhu LM, Nie AF et al (2015) Clinical characteristics of somatic mutations in Chinese patients with aldosterone-producing adenoma. Hypertension 65(3):622\u2013628. \n                    https:\/\/doi.org\/10.1161\/hypertensionaha.114.03346","journal-title":"Hypertension"}],"container-title":["Experientia Supplementum","Genetics of Endocrine Diseases and Syndromes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-25905-1_11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,6]],"date-time":"2019-10-06T17:03:36Z","timestamp":1570381416000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-25905-1_11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030259044","9783030259051"],"references-count":146,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-25905-1_11","relation":{},"ISSN":["1664-431X","2504-3692"],"issn-type":[{"type":"print","value":"1664-431X"},{"type":"electronic","value":"2504-3692"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"7 October 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}